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Objectives: The aim of this study was to determine the antimicrobial susceptibility of Neisseria
gonorrhoeae isolates in the Lao People’s Democratic Republic (Laos).
Methods: A total of 165 gonococcal isolates (1.3%) were obtained from 12 281 genital samples routinely
submitted to a diagnostic laboratory in Vientiane, Laos, between 2011 and 2015. Susceptibility to ﬁve
antibiotics was determined by the standard disk diffusion method for 158 of the isolates.
Results: Rates of resistance to penicillin (by b-lactamase production), tetracycline and ciproﬂoxacin were
89.9%, 99.4% and 84.8%, respectively. All isolates were susceptible to ceftriaxone and spectinomycin.
Conclusions: The situation in Laos is similar to that in neighbouring countries; this fortunately means that
the latest Lao national guidelines for treating gonorrhoea should still be effective.
© 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Chemotherapy of
Infection and Cancer. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).
1. Introduction
There are limited data on the antimicrobial susceptibility of
Neisseria gonorrhoeae isolates in the Lao People’s Democratic
Republic (Laos). This is largely because there are very few
diagnostic microbiology laboratories in the country. Sexually
transmitted infections (STIs) are thus usually managed empirically
based on national guidelines [1]. Previous reports based on
relatively small numbers of isolates have suggested high rates of
antibiotic resistance in Lao isolates of N. gonorrhoeae [2–5,21],
comparable with resistance rates in the neighbouring countries of
Thailand [6], Vietnam [7], Myanmar [8] and southern China [9].
Routine culture for N. gonorrhoeae on all genital tract samples
received in the microbiology laboratory of Mahosot Hospital
(Vientiane, Laos) was introduced in December 2011; previously,
diagnosis of gonorrhoea had relied on microscopy alone. Here we
report the results of culture, including antimicrobial susceptibility
testing, over a 5-year period (2011–2015).
2. Materials and methods
2.1. Patients and sample collection
Female patients with vaginal discharge who visited the
gynaecology outpatient department (OPD) of Mahosot Hospital
were examined by the ward gynaecologists or residents, and
vaginal or endocervical swabs were taken and sent immediately
(within 2 h) to the microbiology laboratory in Amies transport
medium with charcoal (Oxoid Ltd., Basingstoke, UK). Male patients
with urethral discharge who visited the general OPD of the hospital
were referred to the microbiology laboratory for sample collection
by laboratory staff.
2.2. Culture for Neisseria gonorrhoeae
Swabs were streaked on the surface of selective culture medium
for N. gonorrhoeae [Oxoid GC agar base (CM0367) + 1% haemoglo-
bin + Vitox + VCAT antibiotic supplement; Oxoid Ltd.] and were
incubated at 35–37 C in air enriched with 5% CO2. Plates were
examined after 18–24 h and were re-incubated for a further 24 h if
they were culture-negative. Neisseria gonorrhoeae was suspected if
the plate grew oxidase-positive Gram-negative diplococci and was
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conﬁrmed by biochemical (API NH Kit; bioMérieux, Basingstoke,
UK) and serological (RemelTM PhadebactTM Monoclonal GC Test;
Launch Diagnostics Ltd., Longﬁeld, UK) methods.
2.3. Antimicrobial susceptibility testing
Isolates conﬁrmed as N. gonorrhoeae were tested for antimi-
crobial susceptibility by the disk diffusion method on the medium
described above without the selective supplement and incubation
at 35–37 C in 5% CO2 for 20–24 h. Results were interpreted
according to the Clinical and Laboratory Standards Institute (CLSI)
disk diffusion standards current at the time [10]. Neisseria
gonorrhoeae ATCC 49226 was used as a control, which was tested
weekly. The tested antibiotics were ceftriaxone (30 mg), spectino-
mycin (100 mg), ciproﬂoxacin (5 mg), penicillin G (10 U) and
tetracycline (30 mg). b-Lactamase detection was undertaken using
Ceﬁnase disks (BD BBLTM; Zuellig Pharma, Bangkok, Thailand).
2.4. Analysis
Data were entered into Microsoft Excel (Microsoft Corp.,
Redmond, WA) and analyses were done using STATA v.12.0
(StataCorp LP, College Station, TX).
3. Results
3.1. Neisseria gonorrhoeae culture
A total of 12 281 genital samples were received between 2011–
2015, of which 12 259 (99.8%) were vaginal or endocervical swabs
and only 22 (0.2%) were male urethral swabs. Patient age ranged
from 2–83 years (median 30 years). Of the patients, 81.0% were
from Vientiane Capital, 13.1% were from other provinces and no
information about residence was available for 5.9%. Overall, N.
gonorrhoeae was cultured from 165 (1.3%) of the 12 281 samples,
including 9 (40.9%) of 22 urethral swabs and 156 (1.3%) of 12 259
vaginal swabs. Gram-negative diplococci were seen on microscopy
in 46 samples (27.9% of culture-positive samples), of which all but
one grew N. gonorrhoeae (Table 1).
3.2. Antimicrobial susceptibility testing
Disk diffusion susceptibility results were available for 158 of the
165 isolates. All of the isolates were susceptible to ceftriaxone and
spectinomycin. For ciproﬂoxacin, 134 isolates (84.8%) were
resistant, 21 (13.3%) were classiﬁed as intermediate and only 3
(1.9%) were susceptible (Table 2). All isolates were classiﬁed as
either intermediate or resistant to penicillin and tetracycline and
were positive for b-lactamase production.
4. Discussion
This is the ﬁrst study in Laos to look at the value of introducing
routine culture for N. gonorrhoeae of genital samples submitted to a
diagnostic laboratory. The overall yield from samples from females
was relatively low (1.3%), but urethral swabs from men with
urethral discharge, although few in number, were frequently
positive (9/22; 40.9%). Genitourinary medicine specialists do not
exist in Laos and therefore samples were submitted by clinicians
without speciﬁc training in specimen collection techniques, and
the yield might have been increased had all women had urethral
and endocervical swabs taken as opposed to ‘high vaginal’ swabs
[11].
In this population, the overall prevalence of gonorrhoea (1.3%)
was lower than that in a previous study in Laos (3.7%) [5]. This
latter study speciﬁcally recruited women aged between 15–49
years attending the gynaecology OPD for the ﬁrst time, a group that
might be expected to have a higher prevalence of gonococcal
infection than the unselected genital samples submitted to the
laboratory in the current study [12]. None the less, introduction of
culture into routine laboratory testing of genital samples at
Mahosot Hospital enabled the conﬁrmation of gonorrhoea in 120
patients in whom it would not have been detected by microscopy
alone. It is well known that microscopy has a sensitivity of 95% in
males but only 40–60% in females compared with 85–100% for
culture [13,14]. This is particularly important in women in whom
gonococcal infection is frequently asymptomatic [5] but 10–20%
are at risk of complications such as pelvic inﬂammatory disease
and infertility if infection goes undiagnosed and therefore
untreated [11,15]. Molecular diagnostics, which have even greater
sensitivity for the detection of N. gonorrhoeae, are not yet widely
available in Laos.
As expected, resistance to penicillin and tetracycline was very
common (89.9% and 99.4%, respectively). These drugs have not
been recommended for the treatment of gonococcal infection for
many years because of the known high resistance rates amongst
gonococci worldwide [11].
This study also found that 84.8% of Lao N. gonorrhoeae were
resistant to ciproﬂoxacin, with only 1.9% fully susceptible. This is a
higher proportion than found in previous studies of smaller
numbers of isolates from Laos: reduced quinolone susceptibility
rates were reported to be 20% in 2000–2001 [5], 75.9% in 2002 [2],
65.5% in 2005 [3], 33% in 2007 [4] and 11% in 2008 [4]. In another
study in Laos, ciproﬂoxacin resistance in N. gonorrhoeae was found
to increase from 11.9% in 2000 to 69.5% in 2002 [21]. We suggest
that N. gonorrhoeae from Laos should be considered likely to be
quinolone-resistant unless proven otherwise. This is similar to the
situation in Thailand [6], Vietnam [7], Myanmar [8], China [9],
Bangladesh [16] and many other regions [17–20]. Therefore,
ciproﬂoxacin should no longer be used for treatment of gonococcal
infection. Unfortunately, the current national guidelines for Laos,
issued in 2012, include ciproﬂoxacin, oﬂoxacin and norﬂoxacin as
possible ﬁrst-line treatments for gonorrhoea [1]. These agents are
no longer recommended in updated national guidelines produced
in 2016, with only ceftriaxone, ceﬁxime or spectinomycin
recommended as ﬁrst-line agents. These recommendations are
consistent with our ﬁndings. Although single isolates of N.
gonorrhoeae were reported to be resistant to ceftriaxone and
spectinomycin in the study of Phanthouamath et al. [21] these
results were not independently conﬁrmed and there is no evidence
Table 1
Detection rates by microscopy and culture, according to patient sex.
Microscopy Neisseria gonorrhoeae culture Total
Growth No growth
Female Male Female Male
Gram-negative diplococci not
observed
119 1 12102 13 12 235
Gram-negative diplococci observed 37 8 1 0 46
Table 2
Antimicrobial susceptibility patterns of Neisseria gonorrhoeae.
Antimicrobial agent No. (%) of isolates
Susceptible Intermediate Resistant
Ceftriaxone 158 (100) 0 (0) 0 (0)
Spectinomycin 158 (100) 0 (0) 0 (0)
Ciproﬂoxacin 3 (1.9) 21 (13.3) 134 (84.8)
Penicillin 0 (0) 16 (10.1) 142 (89.9)
Tetracycline 0 (0) 1 (0.6) 157 (99.4)
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from our study that such strains have persisted in Vientiane.
Unfortunately, these updated guidelines have not yet been issued
and distributed to clinicians.
There were a number of limitations of this study, particularly
the fact that it was performed at only one site, in the Lao capital
Vientiane, and so it is unknown whether signiﬁcant regional
variations in gonococcal susceptibility occur throughout Laos. The
extremely small number of male patients in this study reﬂects the
fact that when they have STI symptoms, they usually visit the
general OPD or the dermatology centre where urethral samples are
not usually taken for laboratory investigation. In addition, because
of the retrospective laboratory-based nature of the study, it was
not possible to collect data regarding risk factors or other
epidemiological features that may have been associated with
speciﬁc patterns of resistance, nor did we attempt to undertake
typing to investigate chains of transmission. None the less, the
uniformly high rates of resistance to penicillin, tetracyclines and
quinolones make it relatively unlikely that such associations would
have been found.
In conclusion, the majority of N. gonorrhoeae in Laos are
resistant to ciproﬂoxacin, penicillin and tetracycline but remain
susceptible to ceftriaxone and spectinomycin. Updated national
guidelines for the management of STIs, including gonorrhoea,
should be issued and implemented as soon as possible, and
continued surveillance is essential to detect the emergence of
further resistance.
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